Abstract
Background Many California nail salon workers are low-income Vietnamese women of reproductive age who use nail products daily that contain androgen-disrupting phthalates which may increase risk of male reproductive tract abnormalities during pregnancy. Yet, few studies have characterized phthalate exposures among this workforce.
Objective To characterize individual metabolites and cumulative phthalates exposure among a potentially vulnerable occupational group of nail salon workers.
Study Design We collected 17 post-shift urine samples from Vietnamese workers at six San Francisco Bay Area nail salons in 2011, which were analyzed for four primary phthalate metabolites: mono-n-butyl-, mono-isobutyl-, mono(2-ethylhexyl)-, and monoethyl phthalates (MnBP, MiBP, MEHP, and MEP, respectively) (μg/L). Phthalate metabolite concentrations and a potency-weighted sum of parent compound daily intake (Σandrogen-disruptor, μg/kg/day) were compared to 203 Asian Americans from the 2011– 12 National Health and Nutritional Examination Survey (NHANES) using Student’s t-test and Wilcoxin signed rank test.
Results Creatinine-corrected MnBP, MiBP, MEHP (μg/g), and cumulative phthalates exposure (Σandrogen-disruptor, μg/kg/day) levels were 2.9 (p < 0.0001), 1.6 (p = 0.015), 2.6 (p < 0.0001), and 2.0 (p < 0.0001) times higher, respectively, in our nail salon worker population compared to NHANES Asian Americans. Levels exceeded the NHANES 95th or 75th percentiles among some workers.
Conclusion This pilot study suggests that nail salon workers are disproportionately exposed to multiple phthalates, a finding that warrants further investigation to assess their potential health significance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the U.S. Environmental Protection Agency (FP-91750801-1 and RD-83543301), the National Science Foundation Systems Approach to Green Energy (1144885), and the National Institute of Environmental Health Sciences (P01-ES022841 and 1R56ES019598-01). These funding sources had no involvement in the conduct of the research or preparation of this article.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Disclosure Statement: The author(s) report no conflict of interest.
Financial Support: This work was supported by the U.S. Environmental Protection Agency (FP-91750801-1 and RD-83543301), the National Science Foundation Systems Approach to Green Energy (1144885), and the National Institute of Environmental Health Sciences (P01-ES022841 and 1R56ES019598-01). These funding sources had no involvement in the conduct of the research or preparation of this article.
Data Availability
Data available upon request.
